The antiproliferative effect of arctiin on several types of human cancer cells, including osteosarcoma, colorectal cancer, melanoma, lung cancer, breast cancer, prostate cancer, and transformed renal cells, was reported to involve the downregulation of cyclin D1 expression [19]. This evidence concerns the gene CCND1 and prostate carcinoma.